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1. Introduction 
In the vasculature, nitric oxide (NO) is produced from the endothelium mainly by 
endothelial NO synthase (eNOS), which is activated by agonists such as bradykinin and 
acetylcholine or by shear stress produced by the flowing blood. NO is a potent vasodilator 
and protects blood vessels from thrombosis by inhibiting platelet aggregation and adhesion. 
In addition, endothelial NO possesses multiple anti-atherosclerotic properties, which 
include (i) prevention of leukocyte adhesion to the vascular endothelium and leukocyte 
migration into the vascular wall; (ii) decreased endothelial permeability, reduced influx of 
lipoproteins into the vascular wall and inhibition of low density lipoprotein (LDL) 
oxidation; and (iii) inhibition of DNA synthesis, mitogenesis, and proliferation of vascular 
smooth muscle cells [1, 2]. Recent studies suggest that eNOS is also involved in 
mitochondrial biogenesis, anti-aging effects and extension of lifespan in mammals [3, 4]. 
Based on the abovementioned protective effects of eNOS-derived NO, a pharmacological 
enhancement of NO production is of therapeutic interest. Indeed, numerous Chinese 
medicinal plants, herbal preparations, or isolated compounds thereof have been shown to 
stimulate endothelial NO production, which is likely to be a contributing mechanism for 
their therapeutic effects.  
2. Regulation of endothelial NO production 
Endothelial NO production is regulated at different levels, including 
 Regulation of eNOS expression: expression of the eNOS enzyme is regulated at both the 
transcriptional and post-transcriptional levels. Estrogens, for example, increase eNOS 
expression by stimulating eNOS promoter activity. TNF, on the other hand, reduces 
eNOS expression by destabilizing eNOS mRNA [5, 6]. Several Chinese herbal products 
have been shown to enhance eNOS expression (Table 1). 
 Regulation of eNOS activity by post-translational modifications: the enzymatic activity 
of eNOS is regulated by different cellular events such as increased intracellular Ca2+, 
interactions with substrates, co-factors, adaptors and regulatory proteins, and through 
shuttling between distinct subcellular domains [7]. In addition, eNOS activity is also 
regulated by post-translational modification of the eNOS protein. For example, 
phosphorylation of serine 1177 enhances eNOS activity, whereas phosphorylation of 
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threonine 495 decreases eNOS activity [7]. Recent studies indicate that eNOS activity 
can be also enhanced by SIRT1-mediated deacetylation of lysine residues in the 
calmodulin-binding domain [8].  
 Regulation of eNOS activity by changing the intracellular concentration of asymmetric 
dimethylarginine (ADMA): elevated plasma levels of ADMA have been shown to be 
associated with cardiovascular events and mortality. ADMA is believed to be an 
endogenous eNOS inhibitor, although NO-independent effects of ADMA have also 
been reported [9]. ADMA is formed during proteolysis and is degraded by the 
intracellular enzyme dimethylarginine dimethylaminohydrolase (DDAH). Decreased 
DDAH expression/activity is evident in disease states associated with endothelial 
dysfunction [10].  
 Regulation of eNOS functionality: under a number of pathological conditions, the 
enzymatic reduction of molecular oxygen by eNOS is no longer coupled to L-arginine 
oxidation, resulting in production of superoxide rather than NO. This phenomenon is 
referred to as “eNOS uncoupling” [1, 5]. A number of potential mechanisms have been 
reported to contribute to eNOS uncoupling. Among all of these mechanisms, a 
deficiency of the NOS cofactor tetrahydrobiopterin (BH4) seems to be the primary cause 
for eNOS uncoupling in pathophysiology. In BH4 deficiency, the reduction of molecular 
oxygen still occurs at the heme site of eNOS, but oxidation of the guanidine nitrogen of 
L-arginine is prevented, so that the reduced oxygen comes off the enzyme as 
superoxide [11, 12]. eNOS-mediated superoxide production has been observed in 
animal models of atherosclerosis, hypertension, diabetes mellitus and nitroglycerin 
tolerance, and also in patients with endothelial dysfunction resulting from 
hypercholesterolemia, diabetes mellitus, or essential hypertension, in chronic smokers, 
and in nitroglycerin-treated patients [11, 12]. Thus, eNOS uncoupling turns eNOS from 
a NO-producing protective enzyme into a superoxide-generating deleterious molecule. 
It is therefore of therapeutic interest to reverse eNOS uncoupling and restore eNOS 
functionality. An elevation of endothelial BH4 levels (by enhancing BH4 biosynthesis 
and/or by preventing oxidative stress-mediated BH4 oxidation) may reverse eNOS 
uncoupling [13]. Chinese herbs containing large amounts of polyphenolic compounds 
with antioxidant properties may have the potential to prevent BH4 oxidation and eNOS 
uncoupling.  
 Regulation of NO bioactivity by reducing the levels of reactive oxygen species (ROS): 
NO can be rapidly inactivated by superoxide. A reduction of oxidative stress (by 
downregulating ROS-producing enzymes, upregulating antioxidant enzymes, or by 
ROS scavenging activities) may enhance NO bioactivity by two means: prevention of 
eNOS uncoupling and reduction of superoxide-mediated NO inactivation [1].  
3. Searching for eNOS-enhancing Chinese herbs 
Numerous Chinese herbs have been shown to enhance endothelial NO production. These 
reports are summarized in Table 1. This chapter focuses on our own findings. 
EA.hy 926 cells are an immortalized endothelial cell line derived from human umbilical vein 
endothelial cells (HUVEC). This cell line has been generated by fusing HUVEC with the 
permanent human alveolar epithelial cell line A549 [14]. We cloned the 5’-flanking region 
(3.5 kb in length) of the human eNOS gene into pGL3-neo, which contains a promoterless 
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luciferase reporter gene and a neomycin resistance gene [15]. Stable transfection of EA.hy 
926 cells with this construct (selection using G418) resulted in an immortalized human 
endothelial cell line (termed “stable EA.hy cells” for simplicity) that expresses the luciferase 
gene driven by the human eNOS promoter. Luciferase activity in cell homogenates, which 
can be easily measured in a luminometer or on a chemiluminescence plate reader, is used as 
a determinant of promoter activity of the human eNOS gene.  
To search for eNOS-regulating Chinese herbs, we generated aqueous extracts of 17 herbs 
possessing “circulation-improving” effects according to traditional Chinese medicine (TCM) 
[16]. These were: 
 Angelicae sinensis radix 
 Astragali radix 
 Carthami flos 
 Celosiae semen 
 Chrysanthemi indici flos 
 Eucommiae cortex 
 Ligustici radix 
 Metaphyreum roseum 
 Moutan radicis cortex 
 Paeoniae rubrae radix 
 Panacis notoginseng radix 
 Persicae semen 
 Prunella vulgaris L. 
 Puerariae radix 
 Salviae miltiorrhizae radix 
 Uncariae ramulus et unci 
 Zizyphi spinosae semen 
Human EA.hy 926 endothelial cells stably transfected with a 3.5 kb fragment of the human 
eNOS promoter (stable EA.hy cells) were treated with each extract (corresponding to 5 g of 
raw plant extract per ml) at dilutions of 1:100000 to 1:300 for 18 hours to study their effects 
on eNOS promoter activity. Ten herbal extracts increased eNOS promoter activity in a 
concentration-dependent manner with a maximal effect over 150%: Carthami flos, 
Chrysanthemi indici flos, Eucommiae cortex, Ligustici radix, Paeoniae rubrae radix, Prunella 
vulgaris L., Puerariae radix, Uncariae ramulus et unci, Salviae miltiorrhizae radix and Zizyphi 
spinosae semen. 
These ten herbal extracts were further analyzed in a second screening (RNase protection 
assay) for their effect on eNOS mRNA levels in normal EA.hy 926 cells. In this experiment, 
only Prunella vulgaris L., Salviae miltiorrhizae radix and Zizyphi spinosae semen significantly 
increased eNOS mRNA expression [16]. 
Our screening procedure using stable EA.hy cells has some limitations: (i) it is based on 
eNOS promoter activity and the positive results must be verified by additional methods for 
analyses of mRNA expression to exclude false positive hits. (ii) Herbs/compounds that 
regulate NO production via mechanisms other than modulating eNOS expression will 
provide false negative results. For example, Astragali radix had no effect on eNOS expression 
and was negative in our screening. However, Astragali radix can stimulate NO production 
from eNOS by enhancing eNOS enzymatic activity [17]. Despite of its limitations, this 
screening procedure has the advantages of being a low-cost method of relatively high 
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efficiency which is easy to perform. Because of these strengths, it has also been used by 
pharmaceutical companies in the screening for eNOS enhancers [18]. Based on this 
screening, we have identified Prunella vulgaris L., Salviae miltiorrhizae radix and Zizyphi 
spinosae semen as eNOS-regulating Chinese herbs. 
 
Plant Compounds / 
extracts 
Cells / models Effects on eNOS Additional effects References 
Astragali radix extract HUVEC eNOS activity VEGF, PI3K-Akt, 
angiogenesis 
[17] 
Epimedii herba icariin coronary artery 
isolated from 
canine 
eNOS activity vasodilation [74] 
Ginseng ginsenosides I/R in 
Langendorff 
hearts; HAEC 
eNOS-P cardiac function, 
coronary perfusion 
flow, prostacyclin, 
PI3K-Akt 
[75] 
Ginseng  
(Korean red 
ginseng) 
saponin 
fraction 
Hypertensive rats eNOS activity blood pressure [76] 
Magnolia 
officinalis 
honokiol oxLDL-treated 
HUVEC 
eNOS protein 
expression 
adhesion molecules,  
EC-monocyte 
interaction, 
LDL-oxidation, 
ROS 
[77] 
Panax 
notoginseng 
saponin extract HUVEC / 
zebrafish 
eNOS-P angiogenesis,  
VEGF, PI3K-Akt 
[78] 
Polygonum 
multiflorum 
TSG aorta isolated 
from fat-fed rats 
eNOS 
expression 
endothelial function, 
intimal remodeling , 
iNOS 
[79] 
Pueraria  
lobata 
puerarin fat-fed rats eNOS 
expression 
cholesterol [80] 
Prunella 
vulgaris 
extract EA.hy / HUVEC eNOS 
expression 
NO [16] 
Salvia 
miltiorrhiza  
(Danshen) 
crypto-
tanshinone 
HUVEC eNOS 
expression 
ET-1, NF-B [81] 
magnesium 
lithospermate 
B 
HUVEC 
(hyperglycemia) / 
OLETF rats 
eNOS-P Endothelial function 
Akt, Nrf-2, HO-1 
[82] 
tanshinone IIA angiotensin II-
treated rat cardiac 
fibroblasts  
eNOS-P ET-1, ROS, 
fibroblast 
proliferation  
[83] 
tanshinone IIA renovascular 
hypertension 
model in hamsters 
eNOS 
expression 
eNOS -P 
Vasodilation, 
blood pressure 
[84] 
extract /  
ursolic acid 
EA.hy 926 / 
HUVEC 
eNOS 
expression 
NADPH oxidase [24] 
extract rat hypoxic 
pulmonary 
hypertension 
eNOS 
expression 
media thickening, 
iNOS 
[85] 
Seabuckthorn flavonoids EA.hy 926 eNOS 
expression 
LOX-1, cell death [86] 
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Plant Compounds / 
extracts 
Cells / models Effects on eNOS Additional effects References 
Sophora 
flavescens roots 
matrine RIMEC eNOS 
expression 
IL-6, IL-8 & sICAM-
1 
[87] 
Szechwan 
lovage rhizome 
TMP Cerebral 
vasospasm in 
rabbit 
eNOS 
expression 
cerebral vasospasm [88] 
Xanthoceras 
sorbifolia 
ethanol extract Rat aorta eNOS activity vasodilation [89] 
Zizyphi Spinosi 
semen 
betulinic acid EA.hy / HUVEC eNOS 
expression 
ROS [62] 
Combinations & compounds 
A&A decoction obstructed rat 
kidney 
eNOS activity renal fibrosis, ROS [90] 
ELCAS extract H2O2-treated 
ECV304 
eNOS 
expression 
SOD, CAT, GPx [91] 
Qing Huo Yi 
Hao 
TMP glucose-treated 
bEnd.3 
eNOS-P ROS, Akt, UCP2 [92] 
Refined Qing 
Kai Ling 
injection MCAO in rats eNOS 
expression 
infarct size [93] 
Shen-fu injection myocardial I/R in 
diabetic rats 
eNOS-P infarct size, Akt [94] 
Tongxinluo compound HUVEC / aortic 
rings from rats on 
a methionine-rich 
diet  
eNOS 
expression 
Endothelial 
function, 
PI3K- Akt 
[95] 
myocardial no-
reflow and I/R in 
minipigs 
eNOS-P PKA, infarct size [96] 
A&A, a combination of roots Astragalus membranaceus var. mongholicus and Angelica sinensis; 
bEnd.3, mouse brain microvascular cells; CAT, catalase; EA.hy 926, an immortalized human endothelial 
cell line derived from HUVEC; ECV 304, a misidentified (as endothelial cells) human bladder cell line of 
epithelial origin; ELCAS, an extract of Ligusticum chuanxiong and Angelica sinensis; eNOS-P, eNOS 
phosphorylation at serine 1177; GPx, glutathione peroxidase; HAEC, human aortic endothelial cells; 
HO-1, heme oxygenase-1; H/R, hypoxia/reoxygenation; HUVEC, human umbilical vein endothelial 
cells; I/R, ischemia-reperfusion injury; MCAO, middle cerebral artery occlusion; Nrf-2, nuclear factor 
erythroid 2-related factor-2; OLETF, Otsuka Long-Evans Tokushima Fatty rats; RIMEC, rat intestinal 
microvascular endothelial cells; ROS, reactive oxygen species; SOD, superoxide dismutase; TMP, 
tetramethylpyrazine; TSG, 2,3,4',5-tetrahydroxystilbene 2-O-beta-D-glucoside; UCP2, uncoupling 
protein 2. 
Table 1. Effects of Chinese herbs on endothelial NO production.  
3.1 Prunella vulgaris L. (PVL) 
PVL is used in TCM as well as in Western herbal medicine. In the West, the plant has been 
used primarily as a remedy to alleviate pains in the throat, to treat fevers and to accelerate 
wound healing. Modern pharmacological studies have revealed a wide array of biological 
effects and numerous therapeutic possibilities for the herb, including anti-viral and anti-
bacterial effects, immunomodulatory, anti-allergy and anti-cancer potential, as well as 
antioxidant activity [16]. 
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In TCM, PVL (fruiting spikes) is used as an anti-microbial, anti-inflammatory and anti-
tumor drug [19], but it is also commonly used as a component in combination therapy for 
hypertension.  
PVL extracts relax isolated epinephrine-precontracted rabbit aorta [20]. Intravenous 
injection of PVL saponins results in a reduction of both systolic and diastolic blood 
pressures in anesthetized rats [21]. A PVL-containing Chinese herb combination (consisting 
of Crataegus pinnatifida Bge, Uncariae ramulus et uncis, Alisma orientalis radix and PVL at 
1:1:1:1, w/w) reduces blood pressure and lowers cholesterol and triglyceride in 
hypertensive and hypercholesterolemic patients [22].  
Our study demonstrated that PVL is an effective eNOS-upregulating herb; it significantly 
increases eNOS promoter activity, eNOS mRNA and protein expression and NO production 
in human endothelial cells [16].  
PVL extracts contain a variety of chemical constituents, including triterpenoids (such as 
ursolic acid, betulinic acid, oleanolic acid, vulgarsaponins), steroids (such as -sitosterol, 
stigmasterol, -spinasterol), flavonoids (such as rosmarinic acid, luteolin, cynaroside, 
homoorientin, quercetin), coumarins (such as umbelliferone, scopoletin, esculetin), organic 
acids (such as caffeic acid, palmitic acid, stearic acid, oleic acid, arachidic acid, lauric acid, 
myristic acid), sugars, as well as essential oils [23].  
Importantly, our studies have demonstrated that ursolic acid (also present in Salviae 
miltiorrhizae radix) [24], betulinic acid (also a constituent of Zizyphi spinosae semen) [24], 
luteolin and cynaroside (also constituents of artichoke, Cynara scolymus L.) [25] are eNOS-
upregulating compounds. Ursolic acid and betulinic acid are two of the main PVL 
triterpenoids; luteolin and cynaroside are two of the main PVL flavonoids [23]. Therefore, 
these four compounds, possibly in combination with other yet unidentified compounds, 
may be responsible for the observed eNOS-upregulating effect of PVL. 
Our recent experience indicates that the effects of PVL on eNOS may vary significantly from 
batch to batch. With the last two batches of PVL products we bought recently, we could not 
find any eNOS-enhancing activities. This might be due to concentration variation of the 
active constituents in the PVL plant.  
3.2 Salviae miltiorrhizae radix (Danshen) 
Danshen, the dried root of Salvia miltiorrhiza Bunge (Lamiaceae), is one of the most 
commonly used TCM remedies. A Danshen-containing preparation was the first TCM 
product approved for phase II and III clinical trials by the Food and Drug Administration 
(FDA) [26]. Ancient TCM books describe Danshen as a drug “improving circulation” and 
“removing blood stasis”. Today, Danshen is available in China, Japan, the United States, and 
also in many European countries and is used for the treatment of angina pectoris, 
hyperlipidemia, and acute ischemic stroke [26]. Clinical trials have indicated that Danshen 
preparations are superior to nitroglycerin or isosorbide dinitrate for the treatment of stable 
angina pectoris, with respect to efficacy and side effects [27, 28]. 
Various in vitro and in vivo studies have demonstrated that several constituents of Danshen 
can improve microcirculation, dilate coronary arteries, increase blood flow, and prevent 
myocardial ischemia. Aqueous Danshen extracts and purified active principles of Danshen 
(tanshinones) have been shown to cause vasodilation of coronary, renal, femoral, and 
mesenteric arteries, and suppress systemic blood pressure in rats and rabbits [29, 30]. In a rat 
acute myocardial infarction model, Danshen extracts increased the survival rate and 
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reduced the infarct size to an extent comparable with that of the angiotensin converting 
enzyme inhibitor ramipril [31]. Tanshinone IIA, a pharmacologically active component 
isolated from Danshen, reduced myocardial infarct size by about 50% in a rabbit ischemia-
reperfusion model [32].  
Interestingly, the cardiovascular protective effects of Danshen resemble the action profile of 
endothelium-derived NO. Danshen extracts and constituents inhibit platelet aggregation 
[33] and attenuate neutrophil-endothelial adhesion [34]. Danshen also lowers plasma 
cholesterol levels, enhances smooth muscle apoptosis and attenuates neointimal hyperplasia 
in the balloon-injured abdominal aorta of hypercholesterolemic rabbits [35]. Danshen has 
also been shown to reduce lipid peroxidation, inhibit LDL oxidation, and reduce 
atherosclerosis in cholesterol-fed rabbits [36]. 
In stable EA.hy cells we have identified Danshen as an eNOS-enhancer. Danshen extracts 
increase eNOS promoter activity, eNOS mRNA and protein expression, as well as 
endothelial NO production [24]. Danshen extracts contain large amounts of polyphenolic 
compounds with antioxidant properties [26, 37]. This may prevent BH4 oxidation and eNOS 
uncoupling. 
So far, more than 100 compounds have been isolated and identified from Danshen. Most of 
the lipophilic compounds are diterpene chinone compounds of the tanshinone type, 
including tanshinone I, IIA, and IIB, cryptotanshinone, dihydrotanshinone, and other 
related compounds [26, 37]. Hydrophilic constituents include polyphenolic acids (such as 
various salvianolic acids) and related compounds (such as danshensu, i.e. salvianic acid A, 
protocatechuic aldehyde, and protocatechuic acid); but also rosmarinic acid and isoferulic 
acid. Baicalin and ursolic acid have been isolated from alcohol extracts of Danshen [26]. 
In EA.hy 926 cells, an aqueous extract of Danshen and a methanol extract of the plant 
increase eNOS promoter activity, eNOS mRNA and protein expression. On the contrary, a 
dichloromethane extract does not change eNOS gene expression [24]. Thus, hydrophilic and 
alcohol-soluble, but not lipophilic constituents of Danshen seem to be responsible for its 
eNOS-upregulating effect. Accordingly, the commercially available lipophilic compounds 
(tanshinone I, tanshinone IIA, cryptotanshinone and dihydrotanshinone) of Danshen have 
no effect on eNOS expression in EA.hy 926 cells [24]. We have also tested several 
commercially available hydrophilic compounds, including protocatechuic acid, 
protocatechuic aldehyde, rosmarinic acid, isoferulic acid, salvianic acid A, and salvianolic 
acid B. They show no significant effects on eNOS expression [24]. Therefore, the hydrophilic 
compounds that are responsible for the eNOS-upregulating effect of Danshen still remain to 
be identified. Among the alcohol-soluble compounds, we have found that ursolic acid, but 
not baicalin, significantly enhances eNOS mRNA and protein expression [24]. Therefore, 
ursolic acid is likely to represent one of the compounds responsible for enhanced eNOS 
expression in response to Danshen.  
3.3 Ursolic acid 
Ursolic acid is a secondary plant metabolite not only found in Danshen [38], but also 
widespread in some other plants including apple pomace, rosemary leaves, and sage leaves 
(Salvia officinalis) [39]. This pentacyclic triterpenoid has emerged as a multifunctional 
compound with diverse pharmacological properties, including anticancer, antioxidant, anti-
inflammatory, anti-HIV, antimicrobial, and hepatoprotective activities. Currently, ursolic 
acid is in human clinical trials for treating cancer and skin wrinkles [40, 41]. In addition, 
ursolic acid possesses anti-obestic and anti-diabetic effects. It prevents abdominal adiposity 
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[42, 43], improves pancreatic beta-cell function [44], ameliorates glucose intolerance [45], 
inhibits hepatic glucose production in diabetic mice [46], and inhibits diabetic nephropathy 
[47, 48]. 
Also in the cardiovascular system, ursolic acid shows therapeutic effects. In rat models of 
hypertension, ursolic acid prevents the development of severe hypertension which may be 
attributed to a potent diuretic/saluretic activity and a negative chronotropic effect. In 
addition, ursolic acid shows antihyperlipidemic (reduction of LDL and triglycerides), 
antioxidant (upregulation of glutathione peroxidase, GPx, and superoxide dismutase, SOD), 
and hypoglycemic effects [49].  
The reported effects of ursolic acid on atherogenesis are controversial. TNF-induced E-
selectin expression is shown to be suppressed by ursolic acid via the inhibition of NF-B 
[50]. In the rat carotid artery injury model, ursolic acid has been demonstrated to inhibit 
neointima formation [51]. In contrast, a recent study has shown that oral treatment of 
apolipoprotein E-knockout mice with ursolic acid for 24 weeks accelerates atherosclerotic 
plaque formation in a dose-dependent manner [52]. In the latter study, ursolic acid inhibited 
endothelial proliferation and induced endothelial cell death. Ursolic acid caused DNA 
damage, followed by the activation of a p53-, BAK-, and caspase-dependent cell-death 
pathway [52]. Further studies are needed to clarify this controversy.  
We have provided the first evidence that ursolic acid enhances eNOS mRNA and protein 
expression in human endothelial cells [24]. This leads to increased NO production and 
improved endothelial cell function. In a recent study by Lee et al., treatment of human 
coronary artery endothelial cells with ursolic acid increased tube formation, endothelial cell 
migration capacities and the expression of allograft inflammatory factor-1 (AIF-1, a mediator 
of vasculogenesis) through an NO-related mechanism [53]. In a mouse hind limb ischemia 
model, ursolic acid enhanced eNOS and AIF-1 expression, and increased collateral blood 
flow and capillary density through the induction of neovascularization [53].  
In addition to this stimulatory effect on gene expression observed at concentrations of 1-10 
µM, ursolic acid at higher concentrations also stimulated eNOS activity. In organ chamber 
experiments with isolated rat aorta, ursolic acid (and a methanolic extract of Lepechinia 
caulescens) induced an endothelium-dependent, NO-mediated vasodilation (EC50 for ursolic 
acid 44 µM) [54].  
Ursolic acid also possesses anti-oxidative effects. It has been shown to reduce endothelial 
superoxide production by suppressing the expression of NOX4 [24], which is the 
predominant NADPH oxidase isoform in endothelial cells [55]. In addition, ursolic acid also 
enhances ROS inactivation by upregulating the expression/activity of antioxidant enzymes, 
e.g., GPx and SOD [49]. Thus, ursolic acid may also have the potential to prevent BH4 
oxidation and eNOS uncoupling.  
3.4 Zizyphi spinosae semen (ZSS) 
ZSS is a sedative and hypnotic drug with additional effects on the cardiovascular system 
[19]. ZSS protects cardiomyocytes from ischemic injury, and oxygen and glucose 
deprivation-induced damage of cultured neonatal rat myocardial cells can be markedly 
reduced by ZSS total saponins [56]. Anoxia/reoxygenation of cultured neonatal rat 
myocardial cells results in increased intracellular malondialdehyde and lipid peroxides, 
increased intercellular calcium concentration and decreased SOD activity. All of these 
parameters can be reversed by ZSS total saponins [56, 57].  
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ZSS has also antihypertensive effects. Intravenous injection of an aqueous solution of ZSS 
extract markedly decreases blood pressure in anesthetized rats, dogs, and cats without any 
significant effect on coronary blood flow, heart rate, or myocardial contractility [58]. Oral 
treatment of spontaneously hypertensive rats with ZSS jujubosides resultes in a reduction in 
blood pressure [59]. Blood pressure reduction can be observed as early as 30 min and lasted 
for at least 3.5 h; the effect declined after 7.5 h [59]. Moreover, treatment of 
hypercholesterolemic rabbits with ZSS for three months leads to a reduction in total 
cholesterol, LDL cholesterol and triglycerides, an increase in HDL and a decrease in 
atherosclerotic lesions [60]. 
The molecular mechanisms underlying these cardiovascular effects are poorly understood. 
Interestingly, treatment of rats with ZSS resulted in increased plasma levels of NO through 
unknown mechanisms [61]. We have found that ZSS increases eNOS promoter activity, 
eNOS mRNA and protein expression, as well as NO production in human endothelial cells 
[62]. 
The active constituents of ZSS include saponins, triterpenoids, flavonoids, alkaloids, and 
fatty acids [19, 63, 64]. The most important ZSS saponins are triterpenoid oligoglycosides, 
such as jujubosides A and B. Triterpenoids found in ZSS include betulin and betulinic acid 
[63, 65]. 
Jujuboside A, B and betulin show no effect on eNOS promoter activity or eNOS mRNA 
expression. Interestingly, treatment of human endothelial cells with betulinic acid results in 
a significant up-regulation of eNOS mRNA and protein expression [62]. The content of 
betulinic acid in ZSS is approximately 7 mg/kg [63]. When cells are treated with this ZSS 
extract (concentration of 5 g/ml) at a 1:100 dilution, the estimated final concentration of 
betulinic acid is in the low micromolar range. In our study, betulinic acid increases eNOS 
mRNA expression even at 1 µM. Thus, betulinic acid is likely to be one of the compounds 
responsible for the eNOS up-regulation induced by ZSS [62]. 
3.5 Betulinic acid 
The pentacyclic triterpenoid betulinic acid is not only found in ZSS, but is also widespread 
in fruit peel, leaves and stem bark of several species of plants, including white birch bark 
(Betula pubescens), plane bark (Plantanus acerifolia), rosemary leaves (Rosmarinus officinalis), 
Ber tree (Ziziphus mauritiana) and selfheal (Prunella vulgaris) [39, 66]. The compound is 
mainly known for its anti-tumor, anti-viral and anti-inflammatory activities [66, 67]. Our 
study has identified betulinic acid as an eNOS-stimulating compound [62].  
Interestingly, accumulating data in the recent years support a protective effect of betulinic 
acid in the cardiovascular system. In a rat renal ischemia/reperfusion (I/R) injury model, 
betulinic acid attenuates I/R-induced oxidant responses, inhibits microscopic damage, and 
improves renal function by regulating the apoptotic function of leukocytes and inhibiting 
neutrophil infiltration [68]. Recently, betulinic acid and ursolic acid have been identified as 
selective agonists of the G protein-coupled receptor TGR5, which plays an important role in 
the control of energy metabolism. This suggests the therapeutic potential of betulinic acid 
and ursolic acid for metabolic diseases [69].  
In HUVEC, betulinic acid has been shown to inhibit TNF-induced ROS production and 
NF-B activation. The resulting inhibition of endothelial activation and leukocyte adhesion 
points to a protective role of the compound against vascular inflammation [70]. 
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We have found that betulinic acid upregulates eNOS expression in endothelial cells [62]. As 
mentioned above, upregulation of eNOS does not necessarily result in an increase in 
bioactive NO. Under pathological conditions of oxidative stress, eNOS is often uncoupled 
and dysfunctional. The primary cause of eNOS uncoupling is a deficiency of its cofactor BH4 
due to oxidative stress-mediated oxidation (e.g. by peroxynitrite) [1, 12]. Importantly, 
betulinic acid also reduces the expression of NADPH oxidases (NOX4 and p22phox) [62], a 
major source of ROS in the vasculature [71]. We have demonstrated that betulic acid reduces 
the levels of peroxynitrite in the mouse in vivo [72]. These results suggest the potential of 
betulinic acid to reverse eNOS uncoupling. In a mouse stroke model, betulinic acid 
upregulates eNOS and downregulated NADPH oxidases, events which are associated with 
a reduction in infarct size [72].  
Our recent results indicate that betulinic acid not only enhances eNOS expression but also 
enhances eNOS enzymatic activity. Treatment of human endothelial cells with betulinic acid 
leads to phosphorylation of eNOS at serine 1177 and dephosphorylation of eNOS at 
threonine 495, and an increase in NO production [Hohmann N, Xia N, Forstermann U and 
Li H, unpublished data]. This is consistent with a recent report demonstrating that betulinic 
acid induces an endothelium-dependent, NO-mediated relaxation of isolated rat aorta [73].  
4. Conclusion 
Numerous vasoactive Chinese herbs possess stimulating effects on endothelial NO 
production, e.g. by enhancing eNOS expression and/or by modulating eNOS 
phosphorylation status. Such molecular events are likely to be contributing mechanisms for 
the therapeutic effects of these herbs described in traditional Chinese medicine. 
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practicing TCM. Hopefully, this book will help our readers gain a deeper understanding of the unique
characteristics of Chinese medicine.
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